State Street Corporation 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 12:50 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
1,246,613 1.800% |
-3,170,443 (-71.78%) |
Filing |
| 2024-01-25 07:52 am Purchase |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
4,417,056 6.240% |
1,332,919 (+43.22%) |
Filing |
| 2023-02-07 1:20 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
3,084,137 5.400% |
3,084,137 (New Position) |
Filing |